Vanguard Group Inc Inmune Bio, Inc. Transaction History
Vanguard Group Inc
- $5.46 Trillion
- Q3 2024
A detailed history of Vanguard Group Inc transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 720,712 shares of INMB stock, worth $3.51 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
720,712
Previous 628,299
14.71%
Holding current value
$3.51 Million
Previous $5.54 Million
29.9%
% of portfolio
0.0%
Previous 0.0%
Shares
10 transactions
Others Institutions Holding INMB
# of Institutions
70Shares Held
5.9MCall Options Held
243KPut Options Held
46.4K-
Black Rock Inc. New York, NY813KShares$3.96 Million0.0% of portfolio
-
Praetorian Pr LLC Rincon, PR781KShares$3.8 Million1.64% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$2.9 Million45.87% of portfolio
-
Raymond James Financial Services Advisors, Inc. St. Petersburg, FL369KShares$1.8 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA344KShares$1.68 Million0.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $87.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...